IRE1α and IGF signaling predict resistance to an endoplasmic reticulum stress-inducing drug in glioblastoma cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IRE1α and IGF signaling predict resistance to an endoplasmic reticulum stress-inducing drug in glioblastoma cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-20
DOI
10.1038/s41598-020-65320-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma
- (2019) Chia-Hua Chen et al. JOURNAL OF NEUROSURGERY
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Dual IRE1 RNase functions dictate glioblastoma development
- (2018) Stéphanie Lhomond et al. EMBO Molecular Medicine
- Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
- (2018) Franz L. Ricklefs et al. Science Advances
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells
- (2017) Jeffrey J. Rodvold et al. Science Signaling
- Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives
- (2017) Joanna Obacz et al. Science Signaling
- Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells
- (2017) Jeffrey J. Rodvold et al. Science Signaling
- Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives
- (2017) Joanna Obacz et al. Science Signaling
- Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours
- (2016) D Mahalingam et al. BRITISH JOURNAL OF CANCER
- Immune modulation by ER stress and inflammation in the tumor microenvironment
- (2016) Jeffrey J. Rodvold et al. CANCER LETTERS
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel mechanism of enhancing IRE1α-XBP1 signalling via the PERK-ATF4 pathway
- (2016) Akio Tsuru et al. Scientific Reports
- Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
- (2015) Rajesh Mukthavaram et al. Journal of Translational Medicine
- The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells
- (2015) M Zanetti et al. ONCOGENE
- TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
- (2015) Mohamed Ali Mosrati et al. Oncotarget
- In silico modeling predicts drug sensitivity of patient-derived cancer cells
- (2014) Sandeep C Pingle et al. Journal of Translational Medicine
- Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
- (2014) Pengfei Jiang et al. Journal of Translational Medicine
- Posttranscriptional Regulation of PER1 Underlies the Oncogenic Function of IRE
- (2013) O. Pluquet et al. CANCER RESEARCH
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- p58IPK-Mediated Attenuation of the Proapoptotic PERK-CHOP Pathway Allows Malignant Progression upon Low Glucose
- (2013) Anne-Laure Huber et al. MOLECULAR CELL
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- High-Resolution Mutational Profiling Suggests the Genetic Validity of Glioblastoma Patient-Derived Pre-Clinical Models
- (2013) Shawn E. Yost et al. PLoS One
- Induction of the Unfolded Protein Response Drives Enhanced Metabolism and Chemoresistance in Glioma Cells
- (2013) Laura M. Epple et al. PLoS One
- Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development
- (2013) Jeffrey M. Axten et al. ACS Medicinal Chemistry Letters
- Autocrine control of glioma cells adhesion and migration through IRE1 -mediated cleavage of SPARC mRNA
- (2012) N. Dejeans et al. JOURNAL OF CELL SCIENCE
- GRP78/BiP is a novel downstream target of IGF-1 receptor mediated signaling
- (2012) Kyle T. Pfaffenbach et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule
- (2012) B. C. S. Cross et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans
- (2011) J. Guevara-Aguirre et al. Science Translational Medicine
- Role of telomeres and telomerase in cancer
- (2011) Jerry W. Shay et al. SEMINARS IN CANCER BIOLOGY
- Regulated Ire1-dependent decay of messenger RNAs in mammalian cells
- (2009) Julie Hollien et al. JOURNAL OF CELL BIOLOGY
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started